China Meheco Group Co., Ltd. (SHA: 600056)

Market Cap	15.00B
Revenue (ttm)	35.00B
Net Income (ttm)	829.61M
Shares Out	1.50B
EPS (ttm)	0.55
PE Ratio	18.09
Forward PE	n/a
Dividend	0.21 (2.10%)
Ex-Dividend Date	Jun 27, 2024

Volume	4,186,580
Open	10.10
Previous Close	10.11
Day's Range	10.02 - 10.13
52-Week Range	9.77 - 12.78
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About China Meheco Group

China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1984
• Employees: 8,389
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600056

Financial Performance

In 2023, 600056's revenue was 38.82 billion, an increase of 3.28% compared to the previous year's 37.59 billion. Earnings were 1.05 billion, an increase of 42.47%.